Protein-ligand interactions (PLI) are foundational to small molecule drug design. With computational methods striving towards experimental accuracy, there is a critical demand for a well-curated and diverse PLI dataset. Existing datasets are often limited in size and diversity, and commonly used evaluation sets suffer from training information leakage, hindering the realistic assessment of method generalization capabilities. To address these shortcomings, we present PLIN-DER, the largest and most annotated dataset to date, comprising 449,383 PLI systems, each with over 500 annotations, similarity metrics at protein, pocket, interaction and ligand levels, and paired unbound ( apo ) and predicted structures. We propose an approach to generate training and evaluation splits that minimizes task-specific leakage and maximizes test set quality, and compare the resulting performance of DiffDock when retrained with different kinds of splits.
Protein-protein interactions (PPIs) are fundamental to understanding biological processes and play a key role in therapeutic advancements. As deep-learning docking methods for PPIs gain traction, benchmarking protocols and datasets tailored for effective training and evaluation of their generalization capabilities and performance across real-world scenarios become imperative. Aiming to overcome limitations of existing approaches, we introduce PINDER, a comprehensive annotated dataset that uses structural clustering to derive non-redundant interface-based data splits and includes holo (bound), apo (unbound), and computationally predicted structures. PINDER consists of 2,319,564 dimeric PPI systems (and up to 25 million augmented PPIs) and 1,955 high-quality test PPIs with interface data leakage removed. Additionally, PINDER provides a test subset with 180 dimers for comparison to AlphaFold-Multimer without any interface leakage with respect to its training set. Unsurprisingly, the PINDER benchmark reveals that the performance of existing docking models is highly overestimated when evaluated on leaky test sets. Most importantly, by retraining DiffDock-PP on PINDER interface-clustered splits, we show that interface cluster-based sampling of the training split, along with the diverse and less leaky validation split, leads to strong generalization improvements.
Proteolysis-Targeting Chimeras (PROTACs) represent a novel class of small molecules which are designed to act as a bridge between an E3 ligase and a disease-relevant protein, thereby promoting its subsequent degradation. PROTACs are composed of two protein binding "active" domains, linked by a "linker" domain. The design of the linker domain is challenging due to geometric and chemical constraints given by its interactions, and the need to maximize drug-likeness. To tackle these challenges, we introduce ShapeLinker, a method for de novo design of linkers. It performs fragment-linking using reinforcement learning on an autoregressive SMILES generator. The method optimizes for a composite score combining relevant physicochemical properties and a novel, attention-based point cloud alignment score. This new method successfully generates linkers that satisfy both relevant 2D and 3D requirements, and achieves state-of-the-art results in producing novel linkers assuming a target linker conformation. This allows for more rational and efficient PROTAC design and optimization. Code and data are available at https://github.com/aivant/ShapeLinker.